Jim Cramer Says “I Know Xometry’s Growing Like a Weed”
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on XMTR, citing concerns about margin compression, ERP integration friction, quality control issues, and the sustainability of growth without clear profitability visibility.
Risk: Margin compression due to supplier fragmentation and quality control issues
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Xometry, Inc. (NASDAQ:XMTR) was one of the stocks on Jim Cramer’s radar as he highlighted that semiconductor and AI infrastructure stocks are currently in charge. Answering a caller’s query about the stock during the lightning round, Cramer said:
I know Xometry’s growing like a weed. I’m going to invite Xometry on. I don’t know them well enough to opine on the company, but I do know that it’s in the right space. Let’s get them on the show.
Stock market data. Photo by Burak The Weekender on Pexels
Xometry, Inc. (NASDAQ:XMTR) provides an AI-driven marketplace that connects buyers with manufacturing suppliers. It offers instant quoting, collaboration tools, cloud-based workflow solutions, and industrial sourcing services. The company also supports a wide range of manufacturing and production capabilities, including CNC machining, injection molding, 3D printing, sheet cutting, casting, prototyping, and finishing services. Liberty Park Fund stated the following regarding Xometry, Inc. (NASDAQ:XMTR) in its third quarter 2025 investor letter:
Xometry, Inc. (NASDAQ:XMTR) reported another better-than-expected quarter and continued >40% growth in its enterprise business. We remain positive on the company’s long-term onshoring and network potential, but we have taken some profits as the shares have soared.
While we acknowledge the potential of XMTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Cramer's vague endorsement plus profit-taking after the surge point to limited conviction and valuation risk rather than a durable catalyst."
Cramer's comment on XMTR is thin—he explicitly says he doesn't know the company well enough to opine and is just inviting them on. The Liberty Park note highlights >40% enterprise growth and onshoring tailwinds but also reveals they trimmed after the run-up, implying valuation concerns. The piece quickly pivots to pitching a different AI name as superior with less risk, undercutting any XMTR enthusiasm. Missing context includes post-surge multiples, margin trajectory, and whether AI quoting tools face commoditization or execution risk in scaling the supplier network.
The >40% enterprise growth and onshoring momentum could still drive re-rating if Q3 confirms sustained profitability, making the profit-taking a routine rebalance rather than a red flag.
"Cramer's admission of ignorance combined with insider profit-taking at peak growth rates suggests the bull case is already priced in; downside emerges if enterprise growth decelerates or unit economics deteriorate."
Cramer's endorsement is noise masquerading as insight. He explicitly admits 'I don't know them well enough to opine' — then opines anyway based on sector tailwinds. The real signal is Liberty Park Fund's profit-taking despite >40% enterprise growth, suggesting valuation has already priced in the onshoring narrative. XMTR's marketplace model faces structural headwinds: supplier fragmentation, margin compression as the platform scales, and customer concentration risk. The article conflates 'growing fast' with 'good investment,' which are not synonyms. Without current revenue multiples, growth sustainability metrics, or unit economics — this is a sector bet dressed as stock analysis.
If XMTR achieves 40%+ growth for 3+ years while expanding gross margins through AI-driven efficiency, a 6-8x revenue multiple could be justified, making current valuation a screaming buy for long-term holders.
"XMTR's valuation is currently tethered to top-line growth metrics that mask underlying challenges in achieving sustainable operating leverage and margin expansion."
Xometry (XMTR) is effectively a high-beta play on industrial digitization. While the 40% enterprise growth is impressive, the market is currently pricing in a 'platform' multiple (Price-to-Sales) that assumes sustained hyper-growth. The core risk is that XMTR is essentially a digital broker for manufacturing capacity; as they scale, the customer acquisition costs (CAC) often balloon, putting immense pressure on EBITDA margins. Cramer’s 'right space' comment is superficial—the real question is whether they can achieve operating leverage. Until they demonstrate a clear path to GAAP profitability beyond just top-line revenue expansion, the stock remains a speculative bet on the fragmentation of the global supply chain rather than a fundamental value play.
If Xometry successfully achieves network effects where the supply-side density creates a permanent moat, their current revenue growth could justify a valuation re-rating that makes today's price look like a bargain.
"Xometry's growth story may be unsustainable in a high-cost manufacturing marketplace if profitability remains weak and demand cycles soften."
Jim Cramer's call highlights XMTR's top-line momentum and AI-market excitement, but the article doesn't prove the sustainability behind 'growing like a weed.' XMTR's revenue growth—even in enterprise segments—needs to translate into durable profitability. Platform businesses can enjoy rapid top-line expansion while gross margins and take rates compress as competition intensifies and customers negotiate. The onshoring tailwind is policy-driven and may fade or shift, leaving a demand lull. Also, manufacturing procurement cycles are cyclical; a macro slowdown could hit XMTR's deal velocity and enterprise wallet share. Without clear profitability/cash-flow visibility, the stock risks multiple compression if growth cools.
Even with enterprise growth, profitability and cash flow remain uncertain; a tightening pricing/competition dynamic and policy shifts could cap upside and drive multiple compression.
"ERP integration friction poses a bigger adoption hurdle than margin compression or competition."
Claude assumes scaling will compress margins via supplier fragmentation, yet overlooks how XMTR's AI quoting might instead raise take rates by improving bid efficiency. The unmentioned risk is ERP integration friction at enterprise clients, which could throttle the 40% growth trajectory even if onshoring holds. This operational bottleneck, paired with ChatGPT's cyclical procurement warning, makes sustained re-rating less likely than the Liberty Park trim already signals.
"ERP integration friction could turn 40% growth into a backward-looking metric masking forward execution risk."
Grok flags ERP integration friction as a real operational bottleneck, but underestimates how critical that is to the bull case. If enterprise adoption requires 6-12 month implementations with high failure rates, the 40% growth number becomes a lagging indicator of past wins, not future capacity. That's not a secondary risk—it's the difference between sustainable scaling and a revenue cliff. Nobody's modeled what happens when integration delays hit Q4 pipeline.
"Scaling quality control across a fragmented supplier network poses a greater threat to margins than ERP integration delays."
Claude and Grok are fixated on integration friction, but both ignore the actual unit economics of the marketplace. Xometry’s biggest risk isn't just ERP implementation; it is the 'lemon problem' in quality control. As they scale, maintaining consistent manufacturing tolerances across a fragmented, non-captive supplier base becomes exponentially expensive. If they have to subsidize re-work or quality assurance to retain enterprise clients, their take rate will collapse long before they reach meaningful GAAP profitability.
"XMTR must build a scalable QA moat to avoid margin compression from the lemon problem; otherwise near-term profitability remains unlikely."
Gemini's lemon problem is valid, yet the cure is expensive: XMTR would need a scalable QA/data moat to prevent rework costs from crushing take rates. My guess: unless they can materially reduce supplier QA spend per dollar of revenue, gross margins don't sustainably expand. The counterplay is a data-enabled certification program and preferred-supplier ecosystem—but that implies higher capex and longer path to GAAP profitability. Bearish near-term, contingent on execution.
The panel consensus is bearish on XMTR, citing concerns about margin compression, ERP integration friction, quality control issues, and the sustainability of growth without clear profitability visibility.
None identified
Margin compression due to supplier fragmentation and quality control issues